The prognostic utility of preoperative neutrophil-to-lymphocyte ratio in localized clear cell renal cell carcinoma

Canadian Journal of Urology

Volumn 23, Issue 1, 2016, Pages 8151-8154

  Bazzi, Wassim M ^a   Tin, Amy L ^a   Sjoberg, Daniel D ^a   Bernstein, Melanie ^a   Russo, Paul ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Kidney neoplasms; Renal cell carcinoma; Survival

Indexed keywords

CARCINOMA, RENAL CELL; HUMAN; KIDNEY NEOPLASMS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MORTALITY; NEUTROPHIL; PREOPERATIVE PERIOD; PROGNOSIS;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; NEUTROPHILS; PREOPERATIVE PERIOD; PROGNOSIS;

EID: 84962766276     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66(1):7-30.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420(6917):860-867.
3. Balkwill F, Mantovani A, Inflammation and cancer: back to Virchow? Lancet 2001;357(9255):539-545.
4. Rakoff-Nahoum S. Why cancer and inflammation? Yale J Biol Med 2006;79(3-4):123-130.
5. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000;248(3):171-183.
6. Ramsey S, Lamb GW, Aitchison M, McMillan DC. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer. BJU Int 2008;101(8):959-963.
7. Steffens S, Köhler A, Rudolph R et al. Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer 2012;12:399.
8. Jagdev SPK, Gregory W, Vasudev NS et al. Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein. Br J Cancer 2010;103(11):1649-1656.
9. De Martino M, Klatte T, Seemann C et al. Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC). BJU Int 2013;111(8):E348-E353.
10. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340(6):448-454.
11. Guthrie GJK, Charles K, Roxburgh CSD et al. The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol 2013;88(1):218-230.
12. Ohno Y, Nakashima J, Ohori M et al. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol 2010;184(3):873-878.
13. Hashimoto T, Ohno Y, Nakashima J et al. Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma. World J Urol 2013;31(4):953-958.
14. De Martino M, Pantuck AJ, Hofbauer S et al. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol 2013;190(6):1999-2004.
15. Tsai JC-R, Sheu S-H, Chiu H-C et al. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 2007;23(2):111-118.
16. Imtiaz F, Shafique K, Mirza SS et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 2012;5(1):2.
17. Turkmen K, Guney I, Yerlikaya FH et al. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail 2012;34(2):155-159.
18. Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratis Lek Listy 2001;102(1):5-14.
19. Azab B, Daoud J, Naeem F Ben et al. Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study). Ren Fail 2012;34(5):571-576.
20. Recio-Mayoral A, Banerjee D, Streather C et al. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 2011;216(2):446-451.
21. Pichler M, Hutterer GC, Stoeckigt C et al. Validation of the pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer 2013;108(4):901-907.
22. Lane BR, Babineau D, Kattan MW et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol 2007;178(2):429-434.
23. Sorbellini M, Kattan MW, Snyder ME et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005;173(1):48-51.
24. Leibovich BC, Blute ML, Cheville JC et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003;97(7):1663-1671.
25. Zisman A, Pantuck AJ, Wieder J et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002;20(23):4559-4566.
26. Edge SB, Byrd DR, Compton CC et al. AJCC Cancer Staging Manual. New York, NY:Springer;2010.
27. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150(9):604-612.
28. Fuhrman SA, Lasky LC and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6(7):655-663.
29. Dripps RD, Lamont A and Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961;178:261-266.